ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,162Medicare Part D Prescriptions Filled, Including Refills

Rank: 124 out of 6969

$833K Total Retail Price of All Prescriptions

Rank: 197 out of 6969

554 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 554 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

17% of this provider’s 554 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 13,347 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
OMEPRAZOLE 865 688 1 6
METFORMIN HCL 712 569 2 7
GLIMEPIRIDE 585 491 3 44
GABAPENTIN 510 403 4 17
CARVEDILOL 422 338 5 25
LEVOTHYROXINE SODIUM 389 330 6 5
ATORVASTATIN CALCIUM 353 298 7 11
SIMVASTATIN 328 276 8 1
TAMSULOSIN HCL 327 307 9 23
AMLODIPINE BESYLATE 306 277 10 4
JANUVIA 294 232 11 41
FUROSEMIDE 289 256 12 10
FLUTICASONE PROPIONATE 284 197 13 24
HYDROCODONE-ACETAMINOPHEN 279 225 S3 14 3
LISINOPRIL 268 217 15 2
RANITIDINE HCL 249 219 16 46
MELOXICAM 203 183 17 36
TIZANIDINE HCL 202 169 18 298
CITALOPRAM HBR 201 174 19 34
ALENDRONATE SODIUM 200 200 20 14
PANTOPRAZOLE SODIUM 190 162 21 31
BACLOFEN 184 159 22 86
FLUCONAZOLE 181 107 23 276
LEVOFLOXACIN 180 150 24 109
LOSARTAN-HYDROCHLOROTHIAZIDE 171 138 25 53
BENAZEPRIL HCL 163 139 26 18
HYDROCHLOROTHIAZIDE 163 150 26 8
LOSARTAN POTASSIUM 159 139 28 12
IBUPROFEN 137 125 29 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 129 95 30 28
INSULIN SYRINGE 128 95 31 60
METOPROLOL TARTRATE 127 98 32 13
AMOX TR-POTASSIUM CLAVULANATE 126 87 33 194
LANTUS 118 79 34 50
LIPITOR 113 96 35 89
CRESTOR 113 101 35 39
GLIPIZIDE 113 88 35 21
ACTOS 109 73 38 61
HYDRALAZINE HCL 109 106 38 106
DIOVAN 108 106 40 26
AVODART 102 102 41 108
DIOVAN HCT 101 90 42 57
SPIRIVA 101 98 42 66
POTASSIUM CHLORIDE 99 92 44 30
BENAZEPRIL-HYDROCHLOROTHIAZIDE 97 94 45 132
TERAZOSIN HCL 92 85 46 49
NAMENDA 90 86 47 51
AMITRIPTYLINE HCL 89 74 R 48 87
HUMULIN 70-30 88 56 49 294
TRAZODONE HCL 88 82 49 47
LIDODERM 85 77 51 75
TRAMADOL HCL 84 53 52 27
CYMBALTA 83 68 53 72
ISOSORBIDE DINITRATE 82 79 54 231
ONGLYZA 81 66 55 164
ADVAIR DISKUS 79 52 56 45
MECLIZINE HCL 79 72 56 100
DICLOFENAC SODIUM 78 51 58 78
KLOR-CON 10 76 70 59 160
COLCRYS 76 73 59 211
KETOCONAZOLE 74 61 61 185
AZITHROMYCIN 74 60 61 42
ATENOLOL 71 60 63 9
VOLTAREN 68 56 64 105
SYMBICORT 66 55 65 149
HYDROCORTISONE 66 58 65 218
SERTRALINE HCL 66 37 65 38
DOXEPIN HCL 65 50 68 319
FAMOTIDINE 63 60 69 37
POLYETHYLENE GLYCOL 3350 63 37 69 127
HYDROXYZINE HCL 62 51 R 71 159
TRIAMCINOLONE ACETONIDE 58 42 72 55
VESICARE 56 50 73 163
DEXILANT 55 28 74 110
NITROFURANTOIN MONO-MACRO 53 49 75 216
ALLOPURINOL 51 51 76 35
BENICAR 50 45 77 107
PLAVIX 50 38 77 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.